retatrutide phase 2 trial new england journal of medicine Achieve Your Weight Loss Goals with & Pemvidutide Retatrutide (“reta”) is an experimental

Aaron Shapiro specialize in GLP-1 weight loss treatments, combining medical expertise with personalized care to help you achieve your goals

Gastrointestinal symptoms nausea, diarrhea, constipation are most common, especially early

The structure of the program is designed to provide a unique opportunity to understand both the impact of treatment on and potential interactions between obesity and its common complications, including OSA, OA, T2D and CVD

A little refresher on GLP-1 What is a GLP-1 agonist

You dial your dose, press the pen against your skin, and hold the button for a set count after the dose counter reaches zero